Legg Mason Asset Management Japan decreased its stake in Clorox Co Del (CLX) by 44.44% based on its latest 2018Q3 regulatory filing with the SEC. Legg Mason Asset Management Japan sold 4,400 shares as the company’s stock rose 7.73% while stock markets declined. The hedge fund held 5,500 shares of the specialty chemicals company at the end of 2018Q3, valued at $828,000, down from 9,900 at the end of the previous reported quarter. Legg Mason Asset Management Japan who had been investing in Clorox Co Del for a number of months, seems to be less bullish one the $18.84B market cap company. The stock increased 1.34% or $1.95 during the last trading session, reaching $147.6. About 605,980 shares traded. The Clorox Company (NYSE:CLX) has risen 12.45% since January 31, 2018 and is uptrending. It has outperformed by 12.45% the S&P500. Some Historical CLX News: 15/03/2018 – Cramer also sits down with the CEOs of Intel, HP Inc. and Clorox; 15/05/2018 – Clorox at Deutsche Bank Global Consumer Conference Jun 13; 02/05/2018 – CLOROX 3Q EPS CONT OPS $1.37; 19/04/2018 – Clorox Presenting at Goldman Sachs Global Staples Forum May 8; 12/03/2018 – Clorox Estimates Nutranext Acquisition Will Add to EPS in FY2; 30/03/2018 – Clorox CFO Steve Robb Previously Planned to Continue in Advisory Capacity Until June 30, 2018; 20/04/2018 – DJ Clorox Company, Inst Holders, 1Q 2018 (CLX); 20/03/2018 – VANTERRA CAPITAL SAYS ADDITIONAL TERMS OF TRANSACTION WERE NOT DISCLOSED; 02/05/2018 – Clorox Had Seen FY18 EPS $6.17-$6.37; 12/03/2018 Clorox Announces Agreement To Acquire Nutranext, A Leader In Dietary Supplements

Rand Wealth Llc increased its stake in Cvs Health Corp (CVS) by 42.42% based on its latest 2018Q3 regulatory filing with the SEC. Rand Wealth Llc bought 14,900 shares as the company’s stock declined 3.04% with the market. The institutional investor held 50,028 shares of the medical and nursing services company at the end of 2018Q3, valued at $3.94 million, up from 35,128 at the end of the previous reported quarter. Rand Wealth Llc who had been investing in Cvs Health Corp for a number of months, seems to be bullish on the $85.08 billion market cap company. The stock decreased 0.26% or $0.17 during the last trading session, reaching $65.79. About 4.34 million shares traded. CVS Health Corporation (NYSE:CVS) has risen 3.17% since January 31, 2018 and is uptrending. It has outperformed by 3.17% the S&P500. Some Historical CVS News: 20/03/2018 – CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business; 02/05/2018 – CVS Health 1Q EPS 98c; 13/04/2018 – CVS Health Names Marc-David Munk, MD, MPH, MHCM, as Chief Medical Officer of MinuteClinic and Associate Chief Medical Officer of CVS Health; 08/03/2018 – CVS Health Details Programs and Pricing Transparency Solutions Addressing High Cost Drug Issue at AHIP National Policy Conferen; 06/03/2018 – S&PGR Downgrades CVS Health to ‘BBB’ From ‘BBB+’; 05/03/2018 Asia’s Largest Vending Show CVS and the Official Satellite Show of EuroShop Debut ‘World of Retail’ Exhibition; 14/05/2018 – U.S. to consider expanding Medicare drug price negotiation; 06/03/2018 – CVS Bond Buyers Get $200 Million Windfall After Big Debt Sale; 11/04/2018 – CVS Health is introducing a system to provide customers with greater insight into drug costs and lesser expensive alternatives; 09/04/2018 – TABLE-CVS Bay 2687.T -2017/18 parent forecast

More notable recent The Clorox Company (NYSE:CLX) news were published by: Investorplace.com which released: “5 Reasons This Is the Time to Get into Google Stock – Investorplace.com” on January 24, 2019, also Seekingalpha.com with their article: “Clorox down on lowering FY2019 EPS outlook – The Clorox Company (NYSE:CLX) – Seeking Alpha” published on October 31, 2018, Seekingalpha.com published: “Can Clorox Combat Its Headwinds? – Seeking Alpha” on December 23, 2018. More interesting news about The Clorox Company (NYSE:CLX) were released by: Seekingalpha.com and their article: “In Case Clorox Doesn’t Clean Up – Seeking Alpha” published on November 04, 2018 as well as Seekingalpha.com‘s news article titled: “Clorox shuffles leaders as COO resigns post – Seeking Alpha” with publication date: December 10, 2018.

Legg Mason Asset Management Japan, which manages about $106.28 million US Long portfolio, upped its stake in Amazon Com Inc (NASDAQ:AMZN) by 200 shares to 500 shares, valued at $1.00M in 2018Q3, according to the filing.

Among 18 analysts covering The Clorox Company (NYSE:CLX), 3 have Buy rating, 4 Sell and 11 Hold. Therefore 17% are positive. The Clorox Company had 71 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, September 5 by Jefferies. Morgan Stanley maintained The Clorox Company (NYSE:CLX) rating on Thursday, November 2. Morgan Stanley has “Equal-Weight” rating and $128 target. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, December 16. On Friday, February 26 the stock rating was downgraded by Sterne Agee CRT to “Neutral”. Bank of America upgraded the shares of CLX in report on Thursday, January 4 to “Hold” rating. The stock of The Clorox Company (NYSE:CLX) earned “Sell” rating by UBS on Tuesday, November 3. The firm has “Hold” rating by Jefferies given on Thursday, October 5. Deutsche Bank maintained the shares of CLX in report on Thursday, November 1 with “Sell” rating. The rating was maintained by Wells Fargo on Thursday, January 4 with “Hold”. As per Monday, January 9, the company rating was upgraded by Barclays Capital.

Investors sentiment decreased to 0.86 in 2018 Q3. Its down 0.14, from 1 in 2018Q2. It turned negative, as 39 investors sold CLX shares while 270 reduced holdings. 84 funds opened positions while 181 raised stakes. 95.79 million shares or 1.06% less from 96.82 million shares in 2018Q2 were reported. Ubs Asset Mngmt Americas owns 0% invested in The Clorox Company (NYSE:CLX) for 721,927 shares. First Republic Management accumulated 0.09% or 121,014 shares. Checchi Capital Advisers Limited Liability reported 1,401 shares. 1,325 were reported by Monetary Management Gp. 27,100 were reported by Miracle Mile Advisors Limited Liability Co. Boyar Asset Mngmt has 13,075 shares. Carlton Hofferkamp & Jenks Wealth Mngmt Ltd, Texas-based fund reported 4,220 shares. Birmingham Cap Communications Inc Al accumulated 28,429 shares. 2,862 were reported by Confluence Wealth Mgmt Ltd Co. Fjarde Ap reported 0.08% of its portfolio in The Clorox Company (NYSE:CLX). Caisse De Depot Et Placement Du Quebec owns 5,205 shares or 0% of their US portfolio. 3,843 are owned by Lmr Prns Llp. Fiduciary holds 0.01% or 2,392 shares in its portfolio. Westpac Bk has invested 0% in The Clorox Company (NYSE:CLX). Plante Moran Financial Advsrs Ltd Liability Corp has invested 0.09% in The Clorox Company (NYSE:CLX).

Analysts await The Clorox Company (NYSE:CLX) to report earnings on February, 4 before the open. They expect $1.32 EPS, up 7.32% or $0.09 from last year’s $1.23 per share. CLX’s profit will be $168.50 million for 27.95 P/E if the $1.32 EPS becomes a reality. After $1.62 actual EPS reported by The Clorox Company for the previous quarter, Wall Street now forecasts -18.52% negative EPS growth.

Since August 13, 2018, it had 0 insider buys, and 14 insider sales for $55.11 million activity. $2.03M worth of The Clorox Company (NYSE:CLX) was sold by Barral Diego J on Tuesday, November 6. Willoughby Dawn C sold $501,309 worth of stock or 3,387 shares. Costello Michael R. sold $1.10 million worth of stock or 6,882 shares. The insider GARNER DENISE sold 18,366 shares worth $3.00 million. $56,657 worth of stock was sold by Rendle Linda J on Thursday, September 6. Dorer Benno O had sold 152,449 shares worth $25.13M on Tuesday, December 4.

Rand Wealth Llc, which manages about $862.40 million and $893.00M US Long portfolio, decreased its stake in Comcast Corp New (NASDAQ:CMCSA) by 10,080 shares to 143,537 shares, valued at $5.08 million in 2018Q3, according to the filing. It also reduced its holding in At&T Inc (NYSE:T) by 11,248 shares in the quarter, leaving it with 217,693 shares, and cut its stake in Vanguard Bd Index Fd Inc (BSV).

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “Judge denies shutdown-based request for stay of Aetna-CVS case – Seeking Alpha” on January 11, 2019, also Seekingalpha.com with their article: “CVS inks new PBM contract with Walmart – Seeking Alpha” published on January 18, 2019, Livetradingnews.com published: “CVS Health Corporation (NYSE:CVS) 2019 down to $50 – Live Trading News” on January 02, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Bizjournals.com and their article: “Disney nominates CVS executive to board – L.A. Biz” published on January 11, 2019 as well as Seekingalpha.com‘s news article titled: “Amgen’s Aimovig reportedly excluded from CVS plans – Seeking Alpha” with publication date: January 25, 2019.

Among 28 analysts covering CVS Health (NYSE:CVS), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. CVS Health had 86 analyst reports since July 22, 2015 according to SRatingsIntel. As per Thursday, May 12, the company rating was maintained by Jefferies. The stock of CVS Health Corporation (NYSE:CVS) has “Neutral” rating given on Monday, May 9 by Citigroup. As per Monday, November 2, the company rating was maintained by Oppenheimer. The firm has “Hold” rating given on Friday, June 9 by Jefferies. SunTrust maintained the stock with “Buy” rating in Thursday, January 4 report. Leerink Swann maintained it with “Buy” rating and $85.0 target in Tuesday, November 21 report. Citigroup maintained CVS Health Corporation (NYSE:CVS) rating on Tuesday, February 13. Citigroup has “Neutral” rating and $77 target. Oppenheimer maintained CVS Health Corporation (NYSE:CVS) on Thursday, December 17 with “Outperform” rating. Morgan Stanley upgraded the stock to “Overweight” rating in Friday, January 5 report. The stock of CVS Health Corporation (NYSE:CVS) has “Outperform” rating given on Friday, August 28 by Oppenheimer.